Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.

The British journal of surgery - 14 Oct 2022

Buettner Stefan, Olthof Pim B, Wang Jane, Kreis Martin E, Margonis Georgios A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Codon
Share to Colorectal Neoplasms
Share to Exons
Share to Liver Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Point Mutation

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 35979557
DOI: 10.1093/bjs/znac257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.PMID 35979557Read ↗

KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.Semantic proximity Read ↗

Somatic Mutations in Surgically Treated Colorectal Liver Metastases: An Overview.Semantic proximity Read ↗

The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of "Management of Advanced Primary and Secondary Liver Malignancies".Semantic proximity Read ↗

Letter to the editor: Worse prognosis caused by anti-EGFR treatment in advanced colorectal cancer patients with KRAS mutation.Semantic proximity Read ↗

ASO Author Reflections: Characterizing the Impact of RAS Mutation Location on Outcomes for Colorectal Liver Metastases.Semantic proximity Read ↗

KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicine.Semantic proximity Read ↗

The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer.Semantic proximity Read ↗

ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases.Semantic proximity Read ↗

KRAS mutations in primary and metastatic colorectal cancer.Semantic proximity Read ↗

Gene of the month: KRAS.Semantic proximity Read ↗

From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.Semantic proximity Read ↗

Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.